SecurityN / NetSuite, Inc. (64118Q107)
President & CEONELSON ZACHARY
IndustryPrepackaged Software
Institutional Owners1
Institutional Shares458 - 0.00%
Common Shares Outstanding81,474,696 shares (as of 2016-09-30)
Institutional Value$ 51,000 USD
Related 64118QAB3 / NetSuite, Inc. Bond

Institutional Stock Ownership and Shareholders()

N / NetSuite, Inc. Institutional Ownership

NetSuite, Inc. (NYSE:N) has 1 institutional investors and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 458 shares. Largest shareholders include Mizuho Asset Management Co.,Ltd..
NetSuite, Inc. (NYSE:N) ownership structure shows current positions in the company by institutions and funds, as well as latest changes in position size. Major shareholders can include individual investors, mutual funds, hedge funds, or institutions. The Schedule 13D indicates that the investor holds more than 5% of the company and intends to actively pursue a change in business strategy. Schedule 13G indicates a passive investment of over 5%. Green rows indicate new positions. Red rows indicate closed positions. Click the link icon to see the full transaction history.

File DateFormInvestor Opt Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
($1000)
Current Value
($1000)
Change
(Percent)
2017-02-10 13F-HR BlackRock Investment Management, LLC 19,365 0 -100.00 2,144 0 -100.00
2017-02-10 13F-HR BlackRock Fund Advisors 462,224 0 -100.00 51,164 0 -100.00
2016-11-14 13F-HR Mizuho Asset Management Co.,Ltd. 458 458 0.00 33 51 54.55
2017-01-23 13F-HR KANALY TRUST CO 475 0 -100.00 53 0
2017-02-10 13F-HR BlackRock Institutional Trust Company, N.A. 1,034,655 0 -100.00 114,526 0 -100.00
2017-02-10 13F-HR BlackRock Group LTD 163,416 0 -100.00 18,089 0 -100.00
2017-02-10 13F-HR BlackRock Advisors LLC 48,082 0 -100.00 5,322 0 -100.00
2017-02-10 13F-HR BlackRock Japan Co. Ltd 50,289 0 -100.00 5,566 0 -100.00

Related Articles

BLDP: Ballard Power Systems Analysis and Research Report

2018-08-13 - Asif

Core Business At Ballard, Ballard Power Systems is building a clean energy growth company. Ballard Power Systems is recognized as a world leader in proton exchange membrane (“PEM”) fuel cell power system development and commercialization. The company's principal business is the design, development, manufacture, sale and service of PEM fuel cell products for a variety of applications, focusing on its power product markets of Heavy-Duty Motive (consisting of bus, truck, rail and marine applications), Portable Power, Material Handling and Backup Power, as well as the delivery of Technology Solutions, including engineering services, technology transfer, and the license and sale of its extensive intellectual property portfolio and fundamental knowledge for a variety of fuel cell applications. A fuel cell is an environmentally clean electrochemical device that combines hydrogen fuel with oxygen (from the air) to produce electricity. The hydrogen fuel can be obtained from natural g...

MARA: Marathon Patent Group Analysis and Research Report

2018-08-13 - Asif

Overview Marathon Patent Group was incorporated in the State of Nevada on February 23, 2010 under the name Verve Ventures, Inc. On December 7, 2011, the company changed its name to American Strategic Minerals Corporation and were engaged in exploration and potential development of uranium and vanadium minerals business. In June 2012, the company discontinued its minerals business and began to invest in real estate properties in Southern California. In October 2012, the company discontinued its real estate business when its former CEO joined the firm and the company commenced its IP licensing operations, at which time the Company’s name was changed to Marathon Patent Group, Inc. On November 1, 2017, the company entered into a merger agreement with Global Bit Ventures, Inc. (“GBV”), which is focused on mining digital assets. Marathon Patent Group has since purchased its cryptocurrency mining machines and established a data center in Canada to mine digital assets. Following the me...

ECYT: Endocyte Analysis and Research Report

2018-08-13 - Asif

Business and Organization Endocyte, Inc. is a biopharmaceutical company and leader in developing targeted therapies for the treatment of cancer. The Company uses drug conjugation technology to create novel therapeutics and companion imaging agents for personalized targeted therapies. The agents actively target receptors that are over-expressed on diseased cells relative to healthy cells, such as prostate specific membrane antigen (“PSMA”) in prostate cancer. This targeted approach is designed to safely enable the delivery of highly potent drug payloads. The companion imaging agents are designed to identify patients whose disease over-expresses the target of the therapy and who are therefore more likely to benefit from treatment. In September 2017, the Company entered into a Development and License Agreement (the “License Agreement”) with ABX advanced biochemical compounds – Biomedizinische Forschungsreagenzien GmbH (“ABX”), pursuant to which the Company acquired exclusive ...

Related News Stories

4 Long-Term Winners It’s Time to Unload

2018-07-25 investorplace
When it comes to building a successful investment portfolio, figuring out which stocks to buy is the easy part. The real money is made in knowing when to sell. It’s important strike a good balance between taking profits on high-flying investments and cutting your losses on those that didn’t work out as you planned, but it’s often hard to make a sell decision on a stock that you’ve held on to and finally delivered. (67-2)

Is Hawaiian Holdings A Better Airline Buy Than American Airlines?

2018-07-10 seekingalpha
This study of stock price compounding and information compounding says maybe not. American Airlines (AAL) may be trivially better. (28-0)

Oracle Corporation (ORCL) CEO Safra Catz and Mark Hurd on Q4 2018 Results - Earnings Call Transcript

2018-06-20 seekingalpha
Now, I'd like to turn the call over to Ken Bond, Senior Vice President. Sir, you may begin. (38-0)

Oracle's New Sales Tool To Grow Cloud Business

2018-05-17 seekingalpha
Oracle (NYSE:ORCL) NetSuite has a new sales tool that could make a real dent into cloud sales specifically focused in the CRM space. Cloud sales are the only segments at ORCL experiencing double-digit sales growth and represent the smallest contribution to revenues. ORCL and nFusz Inc. (OTCQB:FUSZ) have finally announced a formal partnership for the widely anticipated rollout of the integration of nFusz’s notifiCRM, the first interactive video-based CRM, into the NetSuite platform. (120-0)

Why Investment Wealth-Builders Seek Leveraged ETFs

2018-04-29 seekingalpha
This article is a deep-dive learning lesson for those new to or confused by our behavioral analysis of Market-Maker price-range forecasts. (80-0)

Silicon Investor Message Boards

This table lists all message boards related to N / NetSuite, Inc. on message board site Silicon Investor.

Buy and Sell Signals, and Other Market Perspectives Buy and Sell Signals, and Other Market Perspectives Buy and Sell Signals, and Other Market Perspectives Computer Learning Computer Learning Computer Learning
Libertarian Discussion Forum Libertarian Discussion Forum Libertarian Discussion Forum The Trump Presidency The Trump Presidency The Trump Presidency
A Real American President: Donald Trump A Real American President: Donald Trump A Real American President: Donald Trump OLED Universal Display Corp OLED Universal Display Corp OLED Universal Display Corp
Technology Stocks u0026 Market Talk With Don Wolanchuk Technology Stocks u0026 Market Talk With Don Wolanchuk Technology Stocks u0026 Market Talk With Don Wolanchuk Formerly About Advanced Micro Devices Formerly About Advanced Micro Devices Formerly About Advanced Micro Devices
Research Frontiers (REFR) Research Frontiers (REFR) Research Frontiers (REFR) Qualcomm Moderated Thread - please read rules before posting Qualcomm Moderated Thread - please read rules before posting Qualcomm Moderated Thread - please read rules before posting
CUSIP: 64118Q107